There were 2,027 press releases posted in the last 24 hours and 440,652 in the last 365 days.

CORRECTION FROM SOURCE - CSE: 2016-0613 - Consolidation - BIOSENTA Inc. (ZRO)


/EINPresswire.com/ -- TORONTO, ONTARIO -- (Marketwired) -- 06/24/16 -- This release corrects and replaces the one sent today at 11:10 am ET. The CUSIP and ISIN have been updated.

BIOSENTA Inc., has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post consolidation share for each fifteen (15) pre consolidation common shares. No fractional shares will be issued. If the Share Consolidation will result in a shareholder holding a fractional post-consolidation Common Share, the number of shares to be issued to such shareholder shall be rounded up to the next higher whole number if the fraction is 0.5 or greater, and rounded down to the next lower whole number if the fraction is less than 0.5.

As a result, the outstanding shares of the company will be reduced to approximately 12,185,695.

The shares will begin trading on a consolidated basis and with a new CUSIP number on June 28, 2016.

The name and symbol will not change.

Please note that all open orders will be cancelled at the end of business Monday, June 27, 2016. Dealers are reminded to re-enter their orders taking into account the share consolidation.


Trading on a Consolidated Basis: June 28, 2016
Record Date: June 30, 2016
NEW CUSIP: 09072N202
NEW ISIN: CA 09072N2023

If you have any questions or require further information, or to be removed from the mailing list please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com.

Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com


Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.